This review will explore the function of S6K1 in aging and its implications in AD, with a particular focus on the mechanistic pathways through which S6K1 influences neurodegeneration and the potential for targeting S6K1 in AD therapy. Here, RPS6KB1 is linked to Alzheimer disease.